Citadel Advisors’s Forbion European Acquisition Corp. Warrants FRBNW Stock Holding History

Citadel Advisors’s Portfolio FRBNW Stock Details FRBNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-363,840	Closed	-$200K	–	15690
2023 Q3	$200K	Sell	363,840 -271,072	-43%	-$157K	﹤0.01%	9909
2023 Q2	$273K	Sell	634,912 -161,856	-20%	-$58.2K	﹤0.01%	9250
2023 Q1	$112K	Buy	796,768 +9,522	+1%	+$1.65K	﹤0.01%	11094
2022 Q4	$114K	Buy	787,246 +23,477	+3%	+$3.35K	﹤0.01%	11042
2022 Q3	$183K	Buy	763,769 +13,569	+2%	+$2.09K	﹤0.01%	10496
2022 Q2	$113K	Buy	750,200 +25,047	+3%	+$7.32K	﹤0.01%	11300
2022 Q1	$290K	Buy	+725,153	New	+$298K	﹤0.01%	10671

Citadel Advisors's FRBNW Position: Q4 2023 in Review

Citadel Advisors sold out of Forbion European Acquisition Corp. Warrants (FRBNW) in Q4 2023, closing a stake of 363,840 shares — an estimated $200K sold.

Citadel Advisors first reported a position in FRBNW in Q1 2022 and held it in 7 quarters. The position peaked at $290K in Q1 2022. 0 funds tracked by Wall St. Rank hold FRBNW as of Q4 2023.

Citadel Advisors reported no remaining Forbion European Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Citadel Advisors sold 363,840 Forbion European Acquisition Corp. Warrants shares in Q4 2023, an estimated $200K.
Citadel Advisors first reported a position in Forbion European Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Citadel Advisors's Forbion European Acquisition Corp. Warrants position peaked at $290K in Q1 2022.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Warrants as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.